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Objectives. This study evaluated the safety and efficacy of a newly
developed puncture-sealing device consisting of subcutaneous bovine
collagen application designed to facilitate local hemostasis after
coronary angioplasty.
Background. The most common local hemostatic procedure
after coronary angioplasty consists of heparin discontinuation
and delayed sheath removal followed by mechanical compression
at the puncture site .
Methods. Between December 1991 and February 1993, 124
patients undergoing coronary angioplasty with either a 6F guiding
catheter followed by a heparin infusion for >12 h or a 7F or Of
guiding catheter with optional heparin infusion were prospectively
randomized to either delayed sheath removal followed by manual
compression (n = 62) or sheath removal immediately after
angioplasty combined with bovine collagen application for punc-
ture site closure (n = 62) . Half of the collagen plugs were
Reported local complication rates after percutaneous femoral
artery puncture vary depending on the type of intervention, the
anticoagulation regimen and the prospective or retrospective
nature of the evaluation. In small prospective trials (1-3),
minor local complications after coronary angiography, such as
local hematomas, ranged from 4% to 26% . In larger retrospec-
tive studies (4-9) in which, only major local complications
requiring surgery or transfusions were reported, local compli-
cation rates after diagnostic coronary angiography were 0 .5%
to 3.5%. These rates do not appear to be higher after angio-
plasty (6-8,10-13). However, with the advent of more aggres-
sive anticoagulation regimens, such as those currently used
after stent implantation, local complication rates have in-
creased to <_8% (14) . This increase has led to the development
of new hemostatic devices for arterial puncture site closure .
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delivered using measured and half using estimated skin-artery
distance. Clinical and duplex sonographic evaluations of the
puncture site were performed 24 h later.
Results
. No significant difference in the incidence of local
hernatomas was observed. Major complications were false aneu-
rysm, venous thrombosis and arterial occlusion. The incidence of
false aneurysm was the same in both groups (4 [711/ol of 62) .
Venous thrombosis (2%) and arterial occlusion (2%) were each
recorded in one patient, both in the collagen application group .
Conclusions. Sheath removal and collagen application with this
new vascular hemostasis device used directly after coronary
angioplasty are not superior to delayed sheath removal after
heparin discontinuation followed by mechanical compression .
Arterial collagen sealing with this device in its current form is
associated with a small but worrisome risk of arterial occlusion .
(J Ain Coll Cardiol 1994;24:655-62)
The system used in this study consists of subcutaneously
applied collagen for local vascular hemostasis (VasoSeal,
Datascope Corporation). Preliminary data (15-17) suggest
that it is safe and effective for puncture site closure .
The present randomized study compared the safety and
efficacy of two hemostatic procedures for arterial puncture site
closure after coronary angioplasty : delayed sheath removal
followed by manual compression versus immediate sheath
removal and subcutaneous collagen application .
Methods
Study design . One hundred twenty-four patients undergo-
ing percutaneous transluminal coronary angioplasty were pro-
spectively randomized to either delayed sheath removal fol-
lowed by manual compression (manual compression group,
n = 62) or immediate sheath removal after coronary angio-
plasty combined with bovine collagen application for puncture
site closure (collagen group, n = 62) . Inclusion criteria were 1)
coronary angioplasty performed with a 6F guiding catheter and
full-dose heparinization for >12 h, or 2) coronary angioplasty
with 7F or 8F guiding catheters and optional subsequent
heparinization. The distribution of patients according to size of
the sheath, anticoagulation regimen after angioplasty and type
0735-1097/94/$7 .00
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Table 1
. Patient Distribution According to Type of Hemostasis,
Poaprocedural Heparin Regimen and Sheath Size
In one (' and two (t patients, respectively, heparin perfusion was stopped
by the operator sl2 h after reviewing coronary angioplasty film . Data arc
txpre+retd ac number ( ,a of patients . There were tut significant dilferenccs
anions graup~-
of hemostasis are summarized in Table 1 . Of the 49 patients
receiving full-dose heparinization, heparin was continued for
>24 h in 4 patients (manual compression group 1, collagen
group 3 because of scent implantation . Exclusion criteria were
1 preexisting local hematoma, and 2 known allergy to colla-
gen products .
Patints. Patient characteristics, coagulation variables, fa-
cility of arterial access, duration of procedure and drug regi-
men before, during and after coronary angioplasty arc re-
ported in Tables 2 and 3. No significant differences between
groups were observed . All patients not pretreated with aspirin
received an intravenous bolus dose of 250 to S00 mg of aspirin
during the procedure. Heparin in a bolus dose of 10,000 to
20,000 IU (as selected by the operator was administered
during angioplasty; ongoing intravenous heparin treatment was
given after angioplasty, Urokinase administration did not differ
significantly between groups .
Puncture technique. The common femoral artery was
punctured 1 to 2 cm below the inguinal fold or at inguinal fold
level in obese patients. The arterial puncture was performed by
modified Seldingcr technique using a beveled thin-walled
18-gauge needle with sharp cutting edge (Homedica-
Hollenstein, Cham, Switzerland with continuous aspiration . A
145-cm long 0.035-in . (0.089-cm guide wire was then threaded
through the iliac artery up to the abdominal aorta before the
needle was removed . Intravascular femoral sheaths, 6F to 8F
(Cordis, Roden, The Netherlands , were used routinely .
Heatostatk device and physician experience. The recently
developed hemostatic device, VasoScal, has two main ele-
ments : I a local, subcutaneously applied hemostatic collagen
plug, and 2 an applicator system. The collagen is isolated after
mechanical and chemical elaboration of bovine achilles ten-
don. Two 80-mg plugs of purified and sterile collagen are
applied subcutaneously directly over the arterial puncture site .
The application system consists of a blunt-tipped dilator, an
113F sheath and two collagen-loaded cartridges (Fig . 1 . The
recommended placement procedure consists of two sequential
step& 1
determination of the skin-artery distance, and 2
actual positioning of the plugs (Fig
. 2 . In step 1, at the
beginning of the catheterization procedure, the needle is
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Table 2. Patient Characteristics and Procedural Aspects at
Puncture Site
Data presented are numb r ( of patients or mean value ! SD. There was
no statislieal dilferenee between the two groups . { fCA eornnary angiuplasty .
clamped at skin level after the artery is punctured, and blood
reflow is obtained through the needle bore Fig. 2, top . This
procedure makes it possible to estimate the skin-artery dis-
tance and choose the appropriate kit for the subcutaneous
depth of the artery seven color-coded kits, ranging from 3 .5 to
7 cm, are available . This is the procedure recommended by
the manufacturer and was applied in 31 50 of the patients
in the collagen group. In the other 31 patients in this group, the
skin-artery distance was estimated while the blunt-tipped
dilator was introduced over the wire and advanced down to the
anterior arterial wall. In step 2, at the end of angioplasty, the
collagen is delivered through the applicator system directly
over the arterial puncture site Fig. 2, bottom . The system is
designed to seal arterial puncture holes associated with the use
of sheaths up to 8F in diameter.
Throughout the study only two operators B.M. and P.U .,
each working alone used the collagen scaling device . The first
plug was used at our institution in June 1991, and both
operators had placed -20 plugs before the prospective ran-
domized evaluation was begun .
Hemostatic procedure. In the manual compression group,
arterial sheath removal was delayed 4 to 6 h after coronary
angioplasty or heparin discontinuation . Manual compression
was applied for 15 to 30 min until local hemostasis was
achieved. In the collagen group, local hemostasis was per-
formed by local collagen application with immediate sheath
removal in the catheterization laboratory followed by a 3- to
5-min period of manual compression . No heparin reversal was
used. If immediate hemostasis was not achieved by local
collagen application, an air cushion compression device
Femostop, Radi Medical Systems, Uppsala, Sweden was
positioned over the puncture site. An inflation pressure of 50
to 100 mm Hg was continuously maintained for up to 6 h . Both
Manual
Compression
Group
(n = 62
Collagen
Group
(n = 62
Male gender 53 (85c 5l (81~~
Age (yr 60-- 11 W-1 12
Body mass index (ratio of body weight
lkgJ to height lcmI
Blood pressure (mm Hg at end of
PTCA
0 .46
i-
0 .06 0.44 ± 0.05
S stolic 122 :t 21 120± 18
Diastolic 7t, _• 11 76 . q
Thromhocytc (I0'lpl 2(41 1 56 273 75
Prothromhin time ((i 86.11 t 16 .3 87.7 ± 16.6
Activated partial thromboplartin time (s 30.11
	
18.8 36.8 ~. 17.2
Fibrinogen (mgtdt 3(4 74 330 135
Direct arterial puncture 59 (95''1 60 (97"1
Duration of procedure (min 1118 32 111 = 36
Manual Compression Group
(n = 62)
Collagen Group
(n = 62)
Sheath Size
Total
Group
(n = 62)
Heparin
>12 h
(n = 24)
Total
Group
(n = 62)
Heparin
>12 h
(n = 25)
6F 6(10%) 5f2I%) • 8(130) 6(24%)t
7F 51(82%) 1o (;)7%)
44(71%) 14(,%-,,)
8F 5(8%) 3(12%)
10(16%) 5(2110)
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Table 3
. Patient Distribution According to Drug Regimen Before, During and After Coronary Angioplasty and Type of Hemostasis
groups were treated with a pressure dressing rolled gauze and
elastic bandage
for >6 h and bed rest for >12 It .
Definitions and evaluation criteria.
Evaluation criteria in-
cluded the immediate effect of bovine collagen application on
local hemostasis. Immediate hemostasis was defined as com-
plete hemostasis after collagen application without conven-
tional compression, After 24 h, hematoma size, arterial bruit
and peripheral pulse were evaluated clinically. A hematoma
was defined as a palpable blood collection and assessed
clinically. Hematomas were classified by their maximal diam-
eter as absent. <10 cm, 10 to 20 cm or >20 cm
. Duplex
sonography Akcuson model 128, 7.5- and 5-MHz probe of
the puncture site was performed after 24 h to evaluate vascular
complications
. A standard reporting technique was used eval-
uating 1
the morphology of pcrivascular structures echo-
graphic imaging assisted by color-coded Doppler signal for
vessel location , and 2
arterial and venous flow and flow
pattern in suspected false aneurysms end arteriovenous fistulas
pulsed and continuous Doppler analysis . A pseudoaneurysm
was defined as a cavity linked to the arterial lumen with
turbulent color flow pattern and biphasic flow specter on
pulsed Doppler analysis
. Two physicians interpreted the ultra-
sound examinations without knowledge of treatment assign-
ment .
Figure 1 . VasoSeal applicator system
.
Data presented are number of patients or mean value
	
SD. PTCA -= coronary angioplasty .
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Statistics . Baseline characteristics were expressed as mean
value ± SD when appropriate
. Continuous variables were
compared with the Mann-Whitney U test for unpaired groups
.
Discrete variables were compared with the chi-square test .
Differences with a p value < 0 .05 were considered statistically
significant .
Results
Immediate hemostasis. Immediate hemostasis after bovine
collagen application for puncture site sealing was achieved in
58 94 of 62 cases whether or not previous skin-artery
measurement had been performed . In four patients immediate
hemostasis was not achieved, and prolonged mechanical com-
pression Femostop had to he used . immediate hemostasis
after manual compression was not an issue as such because it
had to he achieved before application of the pressure dressing .
Results after 24 h
. The distribution of hematomas after
24 h is depicted in Figure 3
. No significant difference in
incidence and size could be observed between manual com-
pression and collagen application
. Hematomas were observed
in 22 36 of 62 patients in the manual compression group
and in 30 48 of 62 in the collagen group
. Very large
hematomas >20 cm were found only in the collagen group
0 vs. 4 [7
] . However, no hematoma required transfusions or
surgery
. Within the collagen group, previous skin-artery mea-
surement did not influence the incidence of hematoma forma-
tion
. Major complications assessed clinically or by duplex
sonography are summarized in Table 4
. The characteristics of
the patients who had a major complication are summarized in
Table 5
. The incidence of false aneurysm was the same in both
groups
; however, venous thrombosis and arterial occlusion
were observed in one patient each after collagen application
.
Venous thrombosis Patient 55 .
A 34-year old hypercholes-
terolemic manual worker presented with clinically apparent
venous thrombosis 3 h after subcutaneous application of the
collagen plug despite ongoing full-dose anticoagulation for
emergency stent implantation
. Puncture of the artery at the
beginning of the procedure had been easy, and the vein had
Before/During PTCA
After PTCA
Manual Compression
Group
n = 62
Collagen Group
n = 62
Manual Compression
Group
n = 62
Collagen Group
n = 62
No. Dose No . Dose
No
.
Dose No . Dose
Oral
Coumadin mg 3 1 .7 ± 0 .6 2 7
3.4±1 .5 4 3±1
Dipyridamole
mg 188 ± 53 I 225 7 204 ? 37 2
188 ± 53
1__ p < 0
.05~J
Oral or intravenous aspirin mg 62 182 ± 139 62 149-1 126 51 114 48 58
112 ± 59
Intravenous heparin IU/It or IU 62 19
.745 ± 4,283
62 19,842 1 4,064
24 1,051 ± 208 25 1,109 ± 144
Intravenous or intracor mart urokinase 10" IU 4 1 9 0 .9 0 .4 - - - -
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E
compression
11F
blunt tip
dilator
11
.5 F sheath
B
measurement of
skin-artery distance
of
compression
arterial sheath
guide wire,
H
not been punctured. After collagen application with the esti-
mation technique, hemostasis was not immediately complete,
and an air cushion compression belt was applied for 3 h . At
duplex ultrasound examination, venous thrombosis extended
from the superficial-femoral-vein to the external and common
femoral vein . The collagen plug was visualized between the
common femoral artery and vein . Phlebography revealed a
long occlusion of both internal and external femoral veins .
Arterial occlusion Patient 106 . A 45-year old office clerk,
hypercholesterolemic and current smoker, developed an arte-
rial occlusion late after collagen application . After previous
needle
clamp
0.035 guide wire
Figure 2
. Technique for application .
Top :
A, At the beginning of the proce-
dure, the artery is punctured with an
18-gauge beveled needle. B, When
blood reflows through the bore, the
skin-artery distance is measured by
clamping the needle at skin level
. Bot-
tom :
A, At the end of the procedure, a
0.035-in . 0.089-cm
guide wire is in-
11 .5 F sheath
sorted through the arterial sheath
. B,
The sheath is removed, leaving the
guide wire within the artery. C, A
blunt-tipped dilator is introduced and
advanced down to the anterior arterial
wall . D, An 11
.517 sheath is inserted
over the dilator. E, The guide wire and
blunt-tipped dilator arc removed
. F,
The collagen-loaded cartridge is in-
serted into the sheath
. G, The collagen
is applied. H, The arterial puncture
site is scaled by collagen .
collagen plug
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easy arterial puncture and an uncomplicated procedure, the 7F
sheath was withdrawn, and collagen plugs were implanted after
previous skin-artery measurement . Immediate hemostasis was
successful. After >12 h the patient was free of symptoms.
There was no local hematoma, and peripheral pulses were
easily palpable . Eighteen hours after the procedure, a bicycle
stress test was performed. During the test the patient reported
sharp pain in the right leg. Clinically the signs of an acute
arterial occlusion were evident as pallor, thermal gradient
distal to the knee and absence of peripheral pulses . Angiogra-
phy revealed occlusion of the right common femoral artery at
JACC Vol . 24, No
. 3
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N
E
0
E
25
S
e
0
50
0
Manual Collagen
n=62 n=62
136
all hematomas
®=Manual
o
	
= estimated
=Collagen skin-artery
M
= measured distance
32
26
101
10 10
- 6
0
< 10 10-20 >20
size of hematoma cm
Figure 3. Incidence of hematomas 24 h after coronary angioplasty . No
significant difference was observed between delayed sheath removal
followed by manual compression or immediate sheath removal and
collagen application . Within the collagen group, previous skin-artery
measurement did not influence the final incidence of hematomas .
puncture site level. Intraoperatively the collagen plug was
found to be dislocated intraarterially and appeared as a
gelatinous mass. Surgical removal was performed with a
Fogarty 4 catheter, and the arteriotomy was closed by venous
patch .
Discussion
Background and objectives . Several large retrospective
studies 6-8,13 have shown that complication rates at the
puncture site are not higher after coronary angioplasty than
after coronary angiography and range between 0 .5 and 3.5 .
An increased risk of local complications after coronary angio-
plasty has been reported 18 to be associated with advanced
age, female gender, thrombolytic therapy and postprocedural
anticoagulation .
With the advent of more aggressive and sustained postpro-
cedural anticoagulation regimens, attempts have been made to
decrease local complications by 1 miniaturization of instru-
ments 19-21 ; 2 use of different arterial puncture sites, such
as transbrachial sites 22-24 ; and 3 development of new
devices for local hemostasis .
VasoSeal, a new hemostatic device, consists of a subcuta-
ne;ously implantable collagen plug for vascular closure of the
arterial puncture site Fig. 1 . Historically the first report of
the clinical use of collagen was made in 1960 by Neuner 25
in
the odontologic field . Since then, its hemostatic properties
have been applied in abdominal and vascular surgery for >20
years 26,27 . The procoagulative properties Arc primarily
linked to platelet adhesion and activation 28,29 and vary
according to the chemical and mechanical properties of the
collagen used 28,30,31 . Anticoagulation and antiaggregation
therapy seem not to affect the hemostatic properties of colla-
gen 32 . Bovine collagen is biodegradable and was reabsorbed
within 4 weeks in animal experiments 33,34 . No pyrogenic or
allergenic reaction has been described in animal 35 or human
15,17 trials.
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Table 4. Major Complications Assessed Clinically and by Duplex
Sonography 4 h After Hemostasis
Collagen
Group
n = 62
Manual Compression
Group Measured Estimated
n = 62 n = 31
n = 31
False aneurysm 4
7 2 3 2 3
Venous thrombosis 0 0
1 2
Arterial occlusion 0
1 2 0
Data presented are number of patients in hemostasis group n = 62 .
There was no statistical difference among groups .
The goal of this randomized trial was to compare the
efficacy and safety of arterial puncture site closure by conven-
tional technique delayed sheath removal 4 to 6 h after
coronary angioplasty or after discontinuation of heparin and
manual compression or by collagen application immediate
sheath removal at the end of the procedure and local, subcu-
taneous collagen plug application .
Incidence of complications. In our prospective, clinically
and duplex sonogiaphically controlled evaluation, the total
local complication rate after coronary angioplasty was 42 26
of 62 in the manual compression group and 58 36 of 62 in
the collagen group p = NS . Minor complications hemato-
mas not needing transfusions were present in 35 22 of 62
in the manual compression group and in 48 30 of 62 in the
collagen group p = NS . This complication rate may appear
excessively high . However, a hypothetic retrospective evalua-
tion of this same series would have resulted in a total compli-
cation rate of 1 .6 in both the manual compression group and
the collagen group one venous thrombosis vs . one arterial
occlusion because neither hematomas not requiring transfu-
sions nor subclinical false aneurysms are reported in retrospec-
tive analysis . This complication rate is of the same magnitude
as that previously reported 6-8,10-13 but does not reflect
actual events at the patient s puncture site .
In our study the incidence of false aneurysm was the same
in both the manual compression and collagen groups 4 [7 ]
vs . 4 [7 ] . Ali eight pseudoaneurysms Table 5
were de-
tected by duplex sonography but were not suspected by clinical
examination because of absence of a pulsating mass or an
arterial bruit . Therefore, they can be considered subclinical
false aneurysms. No patient needed surgery . All could be
treated by local external compression with the duplex cono-
graphic probe . This technique allowed a localized compression
directly on the neck of the false aneurysm 36 .
Thrombosis of the superficial fernoral vein Table 5 oc-
curred in 1 patient despite ongoing full-dose anticoagulation .
A potential explanation for the venous thrombosis was venous
stasis induced by the synergistic action of mechanical external
compression, local hematoma mild <10 cm
and collagen
plug position between vein and artery .
The rate of arterial occlusion after collagen plug application
has ranged from 0 to 1
in reported series 17,37 and was
2 in our series
. This small but worrisome risk of distal
660
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Table S. Characteristics of the 10 Male Patients With a Major Complication
•
	
1 = direct,
easy; > I - multiple, difficult.
embolization of collagen 37 or acute arterial occlusion at the
level of the puncture site might be related to a learning curve .
PotenUal factors influencing results . 1 Learning rune.
The rate of hematoma in the 62 patients in the collagen group
was 55 17 of 31 in those treated early Patients I to 31 in
our experience versus 42 13 of 31 in those treated late
Patients 32 to 62 p = NS . Important hematoma >20 cm
and false aneurysm were equally distributed in the early and
late treatment groups 2 of 31 vs . 2 of 31 and 2 of 31 vs . 2 of
31 . Venous thrombosis occurred after the 27th and arterial
occlusion after the 52nd plug insertion . These data make a
masked learning curve phenomenon unlikely .
2 Operator. Hematoma incidence was 50 0 14 of 28 with
operator B.M. versus 47 16 of 34 with operator P.U . p =
NS and important hematoma and false aneurysm were simi-
larly distributed : 2 of 28 versus 2 of 34, and 2 of 28 versus 2 of
34, respectively. Venous thrombosis and arterial occlusion
were also evenly distributed 1 of 28 vs. I of 34 . These data
make an operator-biased result unlikely .
3 Mode of application. Precise application of the collagen
plug, with slight pressure over the arterial puncture site, is of
particular importance for hemostatic efficacy . However, it also
increases the likelihood of the most feared complication,
arterial occlusion . Two application methods were tested in our
series: 1 that recommended by the manufacturer, with previ-
ous skin-artery depth measurement, and 2 that in which
arterial depth is estimated by careful advancement of the blunt
tip dilator over the wire until the elastic recoil of the anterior
arterial wall is felt . The incidence of total complications did not
differ significantly between the two application methods . Thus,
JACC Vol . 24, No . 3
September 1
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the type of application method does not seem to influence the
incidence of minor or major complications Table 4 , and
previous skin-artery measurement does not reliably exclude
dislocation of collagen into the arterial lumen .
Although these results can be interpreted as initial experi-
ence, the relatively simple design of the device, the absence of
a learning curve and the lack of an operator bias or application
method bias make it unlikely that a substantial improvement of
efficacy will occur over time .
Potential disadvantages of arterial collagen sealing . There
are several additional disadvantages of this device . 1 It must
be used directly after the angiographic or angioplastic proce-
dure. Delayed application is not recommended because of the
potential risk of local infection. However, one study 38
undertook delayed placement without reported infections .
2 Repuncture of the same artery within I month is not
recommended, because biodegradation and reabsorption of
the collagen must be allowed for . Early repuncturing could
carry a risk of potential intraluminal dislocation of the colla-
gen, inducing either local thrombosis or embolization in the
periphery . 3 The late proliferative reaction induced by coJa-
gen, seen in an animal model 33 , could lead to subcutaneous
scar formation and make future arterial access difficult . This
concern is heightened by an anticipated 30 risk of a second
intervention within 6 months 39 . 4 The additional cost of the
device must also be considered.
Potential advantages of arterial collagen sealing. The po-
tential major advantage of this device is to allow immediate
sheath removal and immediate hemostasis, even in patients
with a high level of anticoagulation in a subset of seven
Manual Compression Group
Collagen Group
False Aneurysm
Venous
Thrombosis
Arterial
Occlusion
False Aneurysm
Patient no
.
12 52
96 120 9 25 35 110
55 I1bb
Age yr
68
75 54 74 54 56 53
49 34 45
Body mass index ratio of body
weight lhgl to height lcml
Puncture type
I or >1
0.51
I
0.43
I
0.39
I
1.39
I
0.38
I
0 .39 0.40
I
I
0.44
I
0.43
I
11 .44
I
Sheath size
Drug regimen
Before and
during angioplasty
7F 8F 7F 6F
6F 8F 8F 7F 7F 7F
oral coumadin mg
- - 1
Oral and intnlvenoxu
aspirin my
250
100 351 250 11M Ilk - Ilk
350
1W
Intravenulr., heparin
IU/b IW JU
._
. 20 . 30 - r 15 1,042 10 1 .042 20
-
20
- 311 - 20 1,042 20 1,250 IS
lntravcs ous or intracorunary
urolcinase 10 u
After aagioplasty
ono
- - I
Aspirin mg 100 10
1
Ilk
- IIM 1181 l K Ilk IN 1 8
Coumadin mg - - -
2
Dipyridamolc mg - 225 225 15
1
Intravenous heparin lUlh 1,250
1,042 1 .042
1.142
1 .142 1 .042 1 .Iµ2
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patients, measured activated partial thromboplastin time and
prothrombin time were >200 s and 15 ± 10 , respectively, at
the moment of collagen plug insertion . This is time-saving and
may avoid the infrequent local complications related to leaving
intraarterial sheaths in place for prolonged periods 40 .
Early mobilization has peen suggested by some investiga-
tors 15,17,38,41 as one of the major advantages of collagen
puncture site sealing by VasoSeal . However, none of these
studies had a control group for this issue . Of the two reported
prospective randomized studies comparing collagen applica-
tion with mechanical compression, the first 41 mobilized
patients with collagen after 6 h and kept patients after me-
chanical compression at rest for >12 h and the second 38
collected the data concerning this issue retrospectively . In the
present series consisting of a mixed in-hospital ratient group
with postinfarction coronary angioplasty, stent implantations
and elective angioplasty, time to discharge is unlikely to have
been influenced by puncture site care . Irrespective of the
clinical indication for angioplasty, hospital stay did not differ
significantly between groups manual compression group 5 .7 ±
5.3 days vs. collagen group 5 .2 ± 4.1 days . These data indicate
that the time to mobilization saved by collagen application still
needs further evaluation .
Comparison with previously reported data . Some earlier
studies evaluating the VasoSeal system 17,41 did not take
into account the type of intervention and the anticoagulation
regimen used. Therefore, these results have to be interpreted
with caution . The following comparison focuses on previous
studies evaluating collagen sealing VasoSeal in patients with
a high level of anticoagulation and is limited to major compli-
cations surgery, blood transfusion, false aneurysm or venous
thrombosis .
In patients receiving postprocedural heparin for >24 h, the
data are scarce . In an observational study 16 of 10 such
patients all with stents , immediate hemostasis after sheath
removal was achieved in 9 of the 10 . At 24 h one patient 10
had developed a clinically important hematoma requiring
transfusions . However, in that preliminary report 8 of the 10
patients had a combined hemostatic procedure of collagen and
mechanical compression . Our observations in a similar sub-
group of patients with postprocedural heparin for >24 h three
patients with stent implantation in the collagen group re-
vealed at 24 h one false aneurysm Patient 110 in Table 5 and
one venous thrombosis Patient 55 in Table 5 , a complication
not attributable to the sustained anticoagulation regimen .
However, these data are anecdotal and do not permit a conclusive
statement .
A recent randomized study 38 evaluated prospectively
collagen sealing versus conventional hemostatic technique
mechanical compression for arterial puncture site closure
1 after coronary angiography, 2 after coronary angioplasty
with previous discontinuation of heparin, and 3 directly after
coronary angioplasty. This latter subgroup of 85 patients high
level of anticoagulation at the moment of plug insertion, no
postprocedural heparin treatment presents an opportunity for
comparison with the current series. In the previous study, the
CAMENZIND ET AL.
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incidence of major complications was 7 8 of 85 compared
with 9 4 of 134 in the control group with conventional
hemostatic technique mechanical after heparin discontinua-
tion . In our series, the major complication rates were fairly
similar: 6 10 of 62 in the collagen group and 4 7 of 62
in the manual compression group . The higher incidence of
complications in our series can be explained in part by 1
the
detection of clinically unsuspected false aneurysms duplex
sonographic screening versus clinical evaluation , and 2 the
use in some patients of a postprocedural anticoagulation
regimen after collagen sealing . Analysis of our collagen group
patients according to postprocedural heparin regimen revealed
a major complication rate of 16 4 of 25 in the subgroup
receiving intravenous heparin for > 12 h versus 5 2 of 37 in
the group in which heparin was discontinued p = NS . This
same analysis applied to the manual compression group
showed a major complication rate of 13 3 of 24 in the
continued heparin subgroup versus 3 1 of 38 in the
discontinued heparin subgroup p = NS . This analysis sug-
gests a trend toward an increased incidence of major compli-
cations in patients with maintained postprocedural anticoagu-
!ation . Analysis of the entire study group collagen plus manual
compression group according to postprocedural heparin reg-
imen confirmed previous reports 18 of a significantly higher
risk of local complication 7 of 49 with continued heparin vs . 3
of 75 with discontinued heparin, p = 0 .05 in the subgroup
receiving intravenous heparin for > 12 h . Collagen application
did not decrease the incidence of complications observed with
manual compression 4 of 25 vs. 3 of 24 in the subset of
patients receiving heparin .
Clinical implications . The indications for the use of this
subcutaneous hemostatic device in its current form must be
derived from its established benefits and potential risks . Its
r :cognized benefit is its ability to provide immediate hemosta-
sis even in patients with a high levels of anticoagulation . In
view of the most serious potential risk-arterial occlusion-the
use of this device should be limited to patients requiring
uninterrupted full-dose anticoagulation therapy e.g ., stent
implantation . This indication is based on the hypothesis that
the risk of potential arterial occlusion and the possible long-
term local fibrotic scarring are less worrisome than the poten-
tial consequences of a temporarily diminished anticoagulation
regimen. However, our data suggest that this subcutaneous
hemostatic device in its current form needs further improve-
ment to achieve reliable sustained hemostasis in this subgroup
of patients. At present, this system appears to require the use
of an additional device such as a mechanical compressor in
patients with a prolonged postprocedural anticoagulation reg-
imen.
Conclusions. Subcutaneous application of collagen for arte-
rial puncture site closure has opened the way to immediate sheath
removal after coronary angioplasty in patients with a high level of
anticoagulation . However, our data and previous reports suggest
that the VasoSeal system does not currently possess adequate
efficacy and safety to warrant routine use after angioplasty . Its
potential benefits when combined with mechanical compression
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and applied to patients requiring sustained anticoagulation need
further randomized investigation.
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